| Title : Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes - Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| Author(s) : Vardarli I , Nauck MA , Kothe LD , Deacon CF , Holst JJ , Schweizer A , Foley JE |
| Ref : J Clinical Endocrinology Metab , 96 :945 , 2011 |
| Abstract : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| ESTHER : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedSearch : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedID: 21239518 |
| Title : Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? - Nauck_2011_Diabetologia_54_10 |
| Author(s) : Nauck MA , Vardarli I , Deacon CF , Holst JJ , Meier JJ |
| Ref : Diabetologia , 54 :10 , 2011 |
| Abstract : Nauck_2011_Diabetologia_54_10 |
| ESTHER : Nauck_2011_Diabetologia_54_10 |
| PubMedSearch : Nauck_2011_Diabetologia_54_10 |
| PubMedID: 20871975 |
| Title : Unraveling the science of incretin biology - Nauck_2009_Am.J.Med_122_S3 |
| Author(s) : Nauck MA |
| Ref : American Journal of Medicine , 122 :S3 , 2009 |
| Abstract : Nauck_2009_Am.J.Med_122_S3 |
| ESTHER : Nauck_2009_Am.J.Med_122_S3 |
| PubMedSearch : Nauck_2009_Am.J.Med_122_S3 |
| PubMedID: 19464426 |
| Title : Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study - Nauck_2009_Int.J.Clin.Pract_63_46 |
| Author(s) : Nauck MA , Ellis GC , Fleck PR , Wilson CA , Mekki Q |
| Ref : Int J Clin Pract , 63 :46 , 2009 |
| Abstract : Nauck_2009_Int.J.Clin.Pract_63_46 |
| ESTHER : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedSearch : Nauck_2009_Int.J.Clin.Pract_63_46 |
| PubMedID: 19125992 |
| Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA |
| Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007 |
| Abstract : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| ESTHER : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedID: 17698900 |
| Title : The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans - Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| Author(s) : Meier JJ , Gethmann A , Nauck MA , Gotze O , Schmitz F , Deacon CF , Gallwitz B , Schmidt WE , Holst JJ |
| Ref : American Journal of Physiology Endocrinol Metab , 290 :E1118 , 2006 |
| Abstract : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| ESTHER : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| PubMedSearch : Meier_2006_Am.J.Physiol.Endocrinol.Metab_290_E1118 |
| PubMedID: 16403774 |